| Authors: |
Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Lamberti G; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Puchala SR; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Mahadevan NR; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Lin JR; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA., Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Chowdhury A; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Li YY; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA., Wang X; Harvard School of Public Health, Boston, MA., Spurr L; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA., Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Di Federico A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Venkatraman D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Barrichello AP; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Gandhi M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Vaz VR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Pangilinan AJ; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Haradon D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Lee E; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Gupta H; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Pfaff KL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA., Welsh EL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA., Nishino M; Department of Radiology, Brigham and Women's Hospital, Boston, MA., Cherniack AD; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA., Johnson BE; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Weirather JL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA., Dryg ID; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Sorger P; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA., Santagata S; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA., Umeton R; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA. |
